mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.003 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.003 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.005 |